CD19 and neoplasm: Of note, we also observed a significant reduction in the survival of NOXAKO Nalm6 tumor-bearing mice (Fig. 4d), suggesting that mice xenografted derived from NOXAKO Nalm6 cells exhibited lower susceptibility to CD19 CAR T cells than xenografted mice from sgCONT Nalm6 cells.